Latest Pseudomonas Stories
A team of scientists from the University of Oxford, U.K. have taken lessons from Adam Smith and Charles Darwin to devise a new strategy that could one day slow, possibly even prevent, the spread of drug-resistant bacteria. In a new research report published in the March 2011 issue of GENETICS (http://www.genetics.org), the scientists show that bacterial gene mutations that lead to drug resistance come at a biological cost not borne by nonresistant strains.
Agile Sciencesâ€™ pharmaceutical compounds to be assessed for efficacy against bacterial isolates from cystic fibrosis patients. Raleigh, NC (PRWEB) March 11, 2011 Agile Sciences has been awarded a $75,000 grant from the Cystic Fibrosis Foundation which will facilitate testing of the companyâ€™s lead pharmaceutical compounds toward bacterial isolates from cystic fibrosis patients.
Plants are able to protect themselves from most bacteria, but some bacteria are able to breach their defences.
RICHMOND, Va., March 3, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced today that the Pediatric Committee of the European Medicines Agency (EMA) has issued a positive opinion on the Company's Pediatric Investigation Plan (PIP) for ARIKACE(TM) (liposomal amikacin for inhalation), Insmed's Phase 3-ready compound for cystic fibrosis (CF) Pseudomonas and non-TB mycobacteria (NTM) lung infections.
The bacterium, called Pseudomonas aeruginosa, is the most common cause of persistent and fatal lung infections in cystic fibrosis patients.
Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have revealed a novel molecular mechanism that triggers plant infection by Pseudomonas syringae, the bacteria responsible for bacterial speck in tomatoes.
Researchers at National Jewish Health and the University of Texas Southwestern Medical Center have discovered a new method to fight bacterial infections associated with contact lenses.
WOBURN, Mass. and VEDBAEK, Denmark, Jan. 17, 2011 /PRNewswire/ -- AdvanDx today announced that it has received FDA 510(k) clearance for its GNR Traffic Light(TM) PNA FISH(R) test.
SAN FRANCISCO, Jan. 10, 2011 /PRNewswire/ -- Mpex Pharmaceuticals, Inc.
Genetic resistance to antibiotics is not the only trick bacteria use to resist eradicationâ€“ they also have a second defence strategy known as persistence that can kick in.
Pseudomonas aeruginosa is a common bacterium that can cause disease in animals and humans. It can be found in soil, water, skin flora, and most man-made environments throughout the world. It thrives in normal or hypoxic atmospheres; due to this it has colonized many natural and artificial environments. It can infect animals with damaged tissue or people with reduced immunity. Symptoms are generalized inflammation and sepsis. It can be fatal if colonization occurs in critical body organs,...
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.